• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分子动力学模拟改进对HIV-1蛋白酶抑制剂结合能的预测

Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations.

作者信息

Jenwitheesuk Ekachai, Samudrala Ram

机构信息

Department of Microbiology, University of Washington School of Medicine, Seattle, WA 98195, USA.

出版信息

BMC Struct Biol. 2003 Apr 1;3:2. doi: 10.1186/1472-6807-3-2.

DOI:10.1186/1472-6807-3-2
PMID:12675950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC154089/
Abstract

BACKGROUND

The accurate prediction of enzyme-substrate interaction energies is one of the major challenges in computational biology. This study describes the improvement of protein-ligand binding energy prediction by incorporating protein flexibility through the use of molecular dynamics (MD) simulations.

RESULTS

Docking experiments were undertaken using the program AutoDock for twenty-five HIV-1 protease-inhibitor complexes determined by x-ray crystallography. Protein-rigid docking without any dynamics produced a low correlation of 0.38 between the experimental and calculated binding energies. Correlations improved significantly for all time scales of MD simulations of the receptor-ligand complex. The highest correlation coefficient of 0.87 between the experimental and calculated energies was obtained after 0.1 picoseconds of dynamics simulation.

CONCLUSION

Our results indicate that relaxation of protein complexes by MD simulation is useful and necessary to obtain binding energies that are representative of the experimentally determined values.

摘要

背景

准确预测酶 - 底物相互作用能是计算生物学中的主要挑战之一。本研究描述了通过使用分子动力学(MD)模拟纳入蛋白质柔性来改进蛋白质 - 配体结合能预测。

结果

使用AutoDock程序对通过X射线晶体学确定的25种HIV - 1蛋白酶 - 抑制剂复合物进行对接实验。没有任何动力学的蛋白质刚性对接在实验和计算的结合能之间产生了0.38的低相关性。受体 - 配体复合物的MD模拟在所有时间尺度上相关性都有显著提高。在0.1皮秒的动力学模拟后,实验和计算能量之间获得了最高相关系数0.87。

结论

我们的结果表明,通过MD模拟使蛋白质复合物松弛对于获得代表实验确定值的结合能是有用且必要的。

相似文献

1
Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations.通过分子动力学模拟改进对HIV-1蛋白酶抑制剂结合能的预测
BMC Struct Biol. 2003 Apr 1;3:2. doi: 10.1186/1472-6807-3-2.
2
Estimation of binding free energies for HIV proteinase inhibitors by molecular dynamics simulations.通过分子动力学模拟估算HIV蛋白酶抑制剂的结合自由能。
Protein Eng. 1995 Nov;8(11):1137-44. doi: 10.1093/protein/8.11.1137.
3
How inaccuracies in protein structure models affect estimates of protein-ligand interactions: computational analysis of HIV-I protease inhibitor binding.蛋白质结构模型中的误差如何影响蛋白质-配体相互作用的估计:HIV-1蛋白酶抑制剂结合的计算分析
Proteins. 2006 Nov 1;65(2):407-23. doi: 10.1002/prot.21096.
4
Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibility.HIV-1蛋白酶抑制剂复合物的序列与结构之间的关系:用于分析蛋白质柔韧性的模型系统。
J Mol Biol. 2002 Jan 4;315(1):21-52. doi: 10.1006/jmbi.2001.5173.
5
Molecular dynamics simulations of 14 HIV protease mutants in complexes with indinavir.14种HIV蛋白酶突变体与茚地那韦复合物的分子动力学模拟
J Mol Model. 2004 Dec;10(5-6):373-81. doi: 10.1007/s00894-004-0205-x. Epub 2004 Sep 28.
6
Advances in automated docking applied to human immunodeficiency virus type 1 protease.应用于1型人类免疫缺陷病毒蛋白酶的自动对接技术进展。
Methods Enzymol. 1994;241:354-70. doi: 10.1016/0076-6879(94)41073-9.
7
Prediction of HIV-1 protease inhibitor resistance using a protein-inhibitor flexible docking approach.使用蛋白质-抑制剂柔性对接方法预测HIV-1蛋白酶抑制剂耐药性。
Antivir Ther. 2005;10(1):157-66.
8
HIV-1 protease flaps spontaneously close to the correct structure in simulations following manual placement of an inhibitor into the open state.在将一种抑制剂手动置于开放状态后进行的模拟中,HIV-1蛋白酶的瓣片会自发地闭合至正确结构。
J Am Chem Soc. 2006 Mar 8;128(9):2812-3. doi: 10.1021/ja058211x.
9
X-ray structure and conformational dynamics of the HIV-1 protease in complex with the inhibitor SDZ283-910: agreement of time-resolved spectroscopy and molecular dynamics simulations.与抑制剂SDZ283-910复合的HIV-1蛋白酶的X射线结构和构象动力学:时间分辨光谱与分子动力学模拟的一致性
J Mol Biol. 1999 Mar 5;286(4):1147-59. doi: 10.1006/jmbi.1998.2533.
10
Targeting structural flexibility in HIV-1 protease inhibitor binding.靶向HIV-1蛋白酶抑制剂结合中的结构灵活性。
Drug Discov Today. 2007 Feb;12(3-4):132-8. doi: 10.1016/j.drudis.2006.12.011. Epub 2006 Dec 20.

引用本文的文献

1
Optimal COVID-19 therapeutic candidate discovery using the CANDO platform.使用CANDO平台发现最佳的COVID-19治疗候选药物。
Front Pharmacol. 2022 Aug 25;13:970494. doi: 10.3389/fphar.2022.970494. eCollection 2022.
2
Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK.使用CANDOCK精确预测抑制剂与HIV-1蛋白酶的结合
Front Chem. 2022 Jan 17;9:775513. doi: 10.3389/fchem.2021.775513. eCollection 2021.
3
CANDOCK: Chemical Atomic Network-Based Hierarchical Flexible Docking Algorithm Using Generalized Statistical Potentials.

本文引用的文献

1
Structure-based ligand design for flexible proteins: application of new F-DycoBlock.基于结构的柔性蛋白质配体设计:新型F-DycoBlock的应用
J Comput Aided Mol Des. 2001 Nov;15(11):979-96. doi: 10.1023/a:1014817911249.
2
A genetic algorithm for structure-based de novo design.一种基于结构的从头设计的遗传算法。
J Comput Aided Mol Des. 2001 Oct;15(10):911-33. doi: 10.1023/a:1014389729000.
3
Binding mode prediction for a flexible ligand in a flexible pocket using multi-conformation simulated annealing pseudo crystallographic refinement.
基于化学原子网络的层次化柔性对接算法,利用广义统计势能。
J Chem Inf Model. 2020 Mar 23;60(3):1509-1527. doi: 10.1021/acs.jcim.9b00686. Epub 2020 Mar 3.
4
Computational chemoproteomics to understand the role of selected psychoactives in treating mental health indications.计算化学生物组学理解选定精神活性物质在治疗心理健康指征中的作用。
Sci Rep. 2019 Sep 11;9(1):13155. doi: 10.1038/s41598-019-49515-0.
5
All-Atom Four-Body Knowledge-Based Statistical Potentials to Distinguish Native Protein Structures from Nonnative Folds.全原子四体基于知识的统计势能,用于区分天然蛋白质结构和非天然折叠。
Biomed Res Int. 2017;2017:5760612. doi: 10.1155/2017/5760612. Epub 2017 Oct 8.
6
Combating Ebola with Repurposed Therapeutics Using the CANDO Platform.利用CANDO平台用重新利用的疗法对抗埃博拉病毒。
Molecules. 2016 Nov 25;21(12):1537. doi: 10.3390/molecules21121537.
7
Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.利用CANDO平台探索药物发现与药物再利用中的多药理学
Curr Pharm Des. 2016;22(21):3109-23. doi: 10.2174/1381612822666160325121943.
8
CANDO and the infinite drug discovery frontier.CANDO与无限的药物发现前沿领域。
Drug Discov Today. 2014 Sep;19(9):1353-63. doi: 10.1016/j.drudis.2014.06.018. Epub 2014 Jun 26.
9
ReFlexIn: a flexible receptor protein-ligand docking scheme evaluated on HIV-1 protease.ReFlexIn:一种灵活的受体蛋白-配体对接方案,在 HIV-1 蛋白酶上进行评估。
PLoS One. 2012;7(10):e48008. doi: 10.1371/journal.pone.0048008. Epub 2012 Oct 24.
10
Prediction of HIV-1 protease/inhibitor affinity using RosettaLigand.使用 RosettaLigand 预测 HIV-1 蛋白酶/抑制剂亲和力。
Chem Biol Drug Des. 2012 Jun;79(6):888-96. doi: 10.1111/j.1747-0285.2012.01356.x. Epub 2012 Mar 19.
使用多构象模拟退火伪晶体学精修对柔性口袋中的柔性配体进行结合模式预测。
J Mol Biol. 2001 Nov 30;314(3):607-17. doi: 10.1006/jmbi.2001.5147.
4
Elucidating the inhibiting mode of AHPBA derivatives against HIV-1 protease and building predictive 3D-QSAR models.阐明AHPBA衍生物对HIV-1蛋白酶的抑制模式并建立预测性3D-QSAR模型。
J Med Chem. 2002 Jan 17;45(2):333-43. doi: 10.1021/jm0102710.
5
Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock.自动对接多个目标结构:在AutoDock中纳入蛋白质流动性和结构水的异质性
Proteins. 2002 Jan 1;46(1):34-40. doi: 10.1002/prot.10028.
6
Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.HIV-1蛋白酶中瓣尖卷曲作为底物进入和耐药耐受性的一种机制。
Structure. 2000 Dec 15;8(12):1259-65. doi: 10.1016/s0969-2126(00)00537-2.
7
Computational studies on HIV-1 protease inhibitors: influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models.关于HIV-1蛋白酶抑制剂的计算研究:计算得到的抑制剂-酶结合亲和力对3D-QSAR CoMFA模型统计质量的影响。
J Med Chem. 2000 Nov 16;43(23):4446-51. doi: 10.1021/jm9905357.
8
Recent developments in structure-based drug design.基于结构的药物设计的最新进展。
J Mol Med (Berl). 2000;78(5):269-81. doi: 10.1007/s001090000084.
9
Automated docking of alpha-(1-->4)- and alpha-(1-->6)-linked glucosyl trisaccharides and maltopentaose into the soybean beta-amylase active site.α-(1→4)-和α-(1→6)-连接的葡萄糖基三糖及麦芽五糖自动对接至大豆β-淀粉酶活性位点
Proteins. 2000 Aug 1;40(2):299-309. doi: 10.1002/(sici)1097-0134(20000801)40:2<299::aid-prot100>3.0.co;2-g.
10
Examining methods for calculations of binding free energies: LRA, LIE, PDLD-LRA, and PDLD/S-LRA calculations of ligands binding to an HIV protease.结合自由能计算的检验方法:配体与HIV蛋白酶结合的LRA、LIE、PDLD-LRA及PDLD/S-LRA计算
Proteins. 2000 Jun 1;39(4):393-407.